IONS股票跌至52周新低30.18美元，市场挑战加剧
在其他近期新闻中，Ionis ...
TD Cowen Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price ...
New data shed light on impact of charged ions from coronal mass ejections
A new study has provided precise atomic data that shed light on the impact of charged ions from coronal mass ejections (CMEs) ...
Ionis Pharmaceuticals (NASDAQ:IONS) Coverage Initiated at Redburn Atlantic
Research analysts at Redburn Atlantic began coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) in a ...
Ionis向Sobi授权olezarsen全球商业化权利
Olezarsen目前正在接受欧洲药品管理局对FCS治疗的审查，预计将在今年内获得批准。Sobi在超过30个国家拥有商业存在，将负责在其区域内的监管提交和商业化，并借助其在Waylivra®（欧洲唯一获批的FCS药物）方面的经验。Ionis将从Sobi获得预付款、基于里程碑的付款，以及高达20%中段的年度净销售额分级特许权使用费。
Yahoo Finance8 天
IONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to Sobi
Ionis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive rights to market its wholly owned drug Tryngolza outside the United States ...
Mirage News8 天
Charged Ions' Impact in Coronal Ejections Unveiled
A new study has provided precise atomic data that sheds light on the impact of charged ions from Coronal Mass Ejections (CMEs ...
Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Sell at StockNews.com
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a ...